Regulatory slowdown on GM crop decisions.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to Gregory Jaffe.
Explore the source record for details and available documents.
Transgenic crops have the potential to benefit both developed and developing countries. To ensure safe crops to humans and the environment, a strong, but not stifling, regulatory system needs to be established and properly implemented. This paper explores some essential components of a strong regulatory structure for transgenic crops. First, five different regulatory systems for transgenic crops--the United States, the European Union, South Africa, Taiwan, and Argentina--are described and explained. The major components of those systems are then compared to components necessary to a regulatory system that ensures safe products and engenders public trust. The key components discussed include: (1) mandatory pre-market approval; (2) established safety standards; (3) transparency; (4) public participation; (5) use of outside scientists for expert scientific advice; (6) independent agency decisions; (7) post-approval activities; and (8) enforcement authority and resources. Although no one of the existing systems analyzed adequately achieves all the necessary components of a strong regulatory system, those systems serve as models for deciding which regulatory procedures should be emulated and which should be avoided. A mandatory pre-market approval system that applies established safety standards in procedures that are transparent and allows for public participation with no pre-conceived notions or biases will best achieve both safe products and consumer trust.